Institute of Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, Illinois, USA ; Biological Resources Laboratory, University of Illinois at Chicago, Chicago, Illinois, USA.
Institute of Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Pulm Circ. 2014 Jun;4(2):280-8. doi: 10.1086/675991.
Patients with acute respiratory distress syndrome (ARDS) exhibit elevated levels of interleukin-6 (IL-6), which correlate with increased morbidity and mortality. The exact role of IL-6 in ARDS has proven difficult to study because it exhibits either pro- or anti-inflammatory actions in mouse models of lung injury, depending on the model utilized. In order to improve understanding of the role of this complex cytokine in ARDS, we evaluated IL-6 using the clinically relevant combination of lipopolysaccharide (LPS) and ventilator-induced lung injury (VILI) in IL-6(-/-) mice. Bronchoalveolar lavage fluid (BAL), whole-lung tissue, and histology were evaluated for inflammatory markers of injury. Transendothelial electrical resistance was used to evaluate the action of IL-6 on endothelial cells in vitro. In wild-type mice, the combination model showed a significant increase in lung injury compared to either LPS or VILI alone. IL-6(-/-) mice exhibited a statistically significant decrease in BAL cellular inflammation as well as lower histologic scores for lung injury, changes observed only in the combination model. A paradoxical increase in BAL total protein was observed in IL-6(-/-) mice exposed to LPS, suggesting that IL-6 provides protection from vascular leakage. However, in vitro data showed that IL-6, when combined with its soluble receptor, actually caused a significant increase in endothelial cell permeability, suggesting that the protection seen in vivo was likely due to complex interactions of IL-6 and other inflammatory mediators rather than to direct effects of IL-6. These studies suggest that a dual-injury model exhibits utility in evaluating the pleiotropic effects of IL-6 in ARDS on inflammatory cells and lung endothelium.
患有急性呼吸窘迫综合征 (ARDS) 的患者表现出白细胞介素 6 (IL-6) 水平升高,这与发病率和死亡率增加相关。IL-6 在 ARDS 中的确切作用很难研究,因为它在肺损伤的小鼠模型中表现出促炎或抗炎作用,具体取决于所使用的模型。为了更好地理解这种复杂细胞因子在 ARDS 中的作用,我们使用临床上相关的脂多糖 (LPS) 和呼吸机诱导的肺损伤 (VILI) 组合在 IL-6(-/-) 小鼠中评估了 IL-6。评估了支气管肺泡灌洗液 (BAL)、全肺组织和组织学的损伤炎症标志物。跨内皮电阻用于评估 IL-6 在体外对内皮细胞的作用。在野生型小鼠中,与 LPS 或 VILI 单独作用相比,联合模型显示肺损伤明显增加。与单独 LPS 或 VILI 相比,IL-6(-/-) 小鼠的 BAL 细胞炎症和肺损伤组织学评分明显降低,仅在联合模型中观察到这些变化。在暴露于 LPS 的 IL-6(-/-) 小鼠中观察到 BAL 总蛋白的反常增加,这表明 IL-6 提供了对血管渗漏的保护。然而,体外数据表明,IL-6 与其可溶性受体结合实际上导致内皮细胞通透性显著增加,这表明体内观察到的保护可能是由于 IL-6 和其他炎症介质的复杂相互作用而不是 IL-6 的直接作用。这些研究表明,双重损伤模型在评估 IL-6 在 ARDS 中对炎症细胞和肺内皮的多效性作用方面具有实用性。